Spatz FGIA

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Spatz FGIA sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials none currently recruiting 2 completed upper half by trial count

Spatz FGIA: 2 sponsored US clinical trials, none currently recruiting.

Spatz FGIA sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. The most-studied condition in this pipeline is Obesity, with 2 trials.

Mid-pack sponsor footprint

Spatz FGIA is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Indexed trials (enrollment closed)

2 total, page 1 of 1

COMPLETED

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

NCT05086302
COMPLETED NA

Spatz Adjustable Balloon for Obesity (SABO)

NCT02812160

Therapeutic Areas

Obesity 2

How the Spatz FGIA archive is shaped

2 indexed studies, none listed as recruiting (0% open); 2 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Obesity (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Spatz FGIA: archived-pipeline peers nationwide

Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Spatz FGIA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Spatz FGIA1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Spatz FGIA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Spatz FGIA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Spatz FGIA page

2 registered trials is a research-attention snapshot, not an endorsement of Spatz FGIA or any single study.

  • None of Spatz FGIA's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Obesity is the condition Spatz FGIA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Spatz FGIA pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.